ARCHIVES

Von Eschenbach says he will continue as NCI director and give both jobs “100 percent.”

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Requires Independent Confirmation of Disease Progression in Cooperative Group Trials; Seeks Documentation for Avastin in Breast Cancer.

September 15, 2006

Drug Effectiveness Weakens After Three Years, Study Says

May 27, 2011

In Brief: Mathews Could Help In Fighting OMB Obstruction Of Cancer Program; Easily Wins Senate Approval

August 1, 1975

In Brief: Long Island In, Seattle Out Of Community Based Cancer Program; Six Still In Running

December 10, 1976

NCI Developing Policy On Relations Between Industry, DCT Clinical Trials

July 29, 1983

Cure For Lymphoma Foundation Awards Five; Lefall Honored; AACR Begins New Journal.

November 23, 2001